E. Padillo

625 total citations
14 papers, 532 citations indexed

About

E. Padillo is a scholar working on Molecular Biology, Ophthalmology and Physiology. According to data from OpenAlex, E. Padillo has authored 14 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Ophthalmology and 4 papers in Physiology. Recurrent topics in E. Padillo's work include Receptor Mechanisms and Signaling (5 papers), Glaucoma and retinal disorders (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). E. Padillo is often cited by papers focused on Receptor Mechanisms and Signaling (5 papers), Glaucoma and retinal disorders (4 papers) and Nitric Oxide and Endothelin Effects (3 papers). E. Padillo collaborates with scholars based in United States and Ireland. E. Padillo's co-authors include Daniel W. Gil, Larry A. Wheeler, Jyotirmoy Kusari, Michelle Webster, John E. Donello, J. Burke, Michael E. Garst, A. Kharlamb, Stephen A. Munk and Linda Williams and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

E. Padillo

14 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Padillo United States	11	285	253	100	87	75	14	532
Federica Cavaliere Italy	10	240 0.8×	274 1.1×	47 0.5×	90 1.0×	123 1.6×	13	520
Yasutaka Takagi Japan	10	187 0.7×	221 0.9×	61 0.6×	70 0.8×	23 0.3×	20	475
Andrea Matteucci Italy	15	171 0.6×	314 1.2×	95 0.9×	62 0.7×	125 1.7×	31	629
Juliet A. Moncaster United States	10	89 0.3×	220 0.9×	37 0.4×	74 0.9×	27 0.4×	21	460
Vincent M. Villar Spain	12	72 0.3×	169 0.7×	131 1.3×	32 0.4×	15 0.2×	29	428
Guoge Han China	12	172 0.6×	222 0.9×	51 0.5×	61 0.7×	40 0.5×	31	412
Toshio Narimatsu Japan	8	172 0.6×	194 0.8×	26 0.3×	43 0.5×	38 0.5×	12	363
С. В. Логвинов Russia	10	33 0.1×	157 0.6×	59 0.6×	20 0.2×	45 0.6×	84	425
Lewis H. Silver United States	13	697 2.4×	96 0.4×	24 0.2×	278 3.2×	81 1.1×	16	902
Н. И. Курышева Russia	13	458 1.6×	115 0.5×	5 0.1×	268 3.1×	94 1.3×	88	648

Countries citing papers authored by E. Padillo

Since Specialization

Citations

This map shows the geographic impact of E. Padillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Padillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Padillo more than expected).

Fields of papers citing papers by E. Padillo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Padillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Padillo. The network helps show where E. Padillo may publish in the future.

Co-authorship network of co-authors of E. Padillo

This figure shows the co-authorship network connecting the top 25 collaborators of E. Padillo. A scholar is included among the top collaborators of E. Padillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Padillo. E. Padillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Kusari, Jyotirmoy, E. Padillo, Yanyan Bai, et al.. (2011). Effect of Brimonidine on Retinal and Choroidal Neovascularization in a Mouse Model of Retinopathy of Prematurity and Laser-Treated Rats. Investigative Ophthalmology & Visual Science. 52(8). 5424–5424. 21 indexed citations

Kusari, Jyotirmoy, et al.. (2010). Inhibition of Vitreoretinal VEGF Elevation and Blood–Retinal Barrier Breakdown in Streptozotocin-Induced Diabetic Rats by Brimonidine. Investigative Ophthalmology & Visual Science. 51(2). 1044–1044. 60 indexed citations

Kusari, Jyotirmoy, et al.. (2007). Effect of Memantine on Neuroretinal Function and Retinal Vascular Changes of Streptozotocin-Induced Diabetic Rats. Investigative Ophthalmology & Visual Science. 48(11). 5152–5152. 115 indexed citations

Donello, John E., E. Padillo, Michelle Webster, Larry A. Wheeler, & Daniel W. Gil. (2001). α2-Adrenoceptor Agonists Inhibit Vitreal Glutamate and Aspartate Accumulation and Preserve Retinal Function after Transient Ischemia. Journal of Pharmacology and Experimental Therapeutics. 296(1). 216–223. 41 indexed citations

Donello, John E., E. Padillo, Michelle Webster, Larry A. Wheeler, & Daniel W. Gil. (2001). alpha(2)-Adrenoceptor agonists inhibit vitreal glutamate and aspartate accumulation and preserve retinal function after transient ischemia.. PubMed. 296(1). 216–23. 115 indexed citations

Munk, Stephen A., James A. Burke, E. Padillo, et al.. (1997). Synthesis and Evaluation of 2-(Arylamino)imidazoles as α₂-Adrenergic Agonists. Journal of Medicinal Chemistry. 40(1). 18–23. 40 indexed citations

Munk, Stephen A., Ronald Lai, J. Burke, et al.. (1996). Synthesis and Pharmacologic Evaluation of 2-endo-Amino-3-exo- isopropylbicyclo[2.2.1]heptane: A Potent Imidazoline₁ Receptor Specific Agent. Journal of Medicinal Chemistry. 39(6). 1193–1195. 41 indexed citations

Munk, Stephen A., Charles Gluchowski, James A. Burke, et al.. (1996). Synthesis and Evaluation of 2-[(5-Methylbenz-1-ox-4-azin-6-yl)imino]imidazoline, a Potent, Peripherally Acting α₂Adrenoceptor Agonist. Journal of Medicinal Chemistry. 39(18). 3533–3538. 10 indexed citations

Burke, J., et al.. (1995). Adrenergic and Imidazoline Receptor‐Mediated Responses to UK‐14,304‐18 (Brimonidine) in Rabbits and Monkeys. Annals of the New York Academy of Sciences. 763(1). 78–95. 37 indexed citations

10.

Gluchowski, Charles, Harvey Wong, J. Burke, et al.. (1995). Analogs of UK 14,304: Structural features responsible for α2 adrenoceptor activity. Bioorganic & Medicinal Chemistry Letters. 5(15). 1745–1750. 16 indexed citations

11.

Gluchowski, Charles, Lloyd J. Dolby, Harvey Wong, et al.. (1994). Analogs of UK 14,304 as α2-adrenoceptor agonists. Twist and agent polarity as design elements.. Bioorganic & Medicinal Chemistry Letters. 4(3). 459–462. 15 indexed citations

12.

Woodward, D.F., et al.. (1989). Sustained Decreases in Systemic Blood Pressure Do Not Cause Ocular Hypotension. Ophthalmic Research. 21(1). 37–43. 2 indexed citations

13.

Woodward, David F., et al.. (1986). Pharmacological characterization of β-adrenoceptor subtype involvement in the ocular hypotensive response to β-adrenergic stimulation. Experimental Eye Research. 43(1). 61–75. 11 indexed citations

14.

WONG, A. Y., et al.. (1974). Giycopyrrolate as a Substitute for Atropine in Reversal of Curarization in Pediatric Cardiac Patients. Anesthesia & Analgesia. 53(3). 412???418–412???418. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact